We Must Learn from Our Past
A look at past outbreaks offers guidance on bringing the current one to an end – and on thwarting the next one.
University of California San Francisco
Give to UCSFA look at past outbreaks offers guidance on bringing the current one to an end – and on thwarting the next one.
Joel Ernst, MD, addresses key questions about how vaccine development works and why vaccines are especially important in the case of COVID-19.
UCSF researchers are taking a closer look at COVID-19’s dizzying array of symptoms to get at the disease’s root causes.
Communities of color have been hit hardest by COVID-19. Meanwhile, hundreds of thousands of people have taken to the streets in an outcry against police brutality. Both issues have roots in the same problem.
The pandemic has led to a sudden rise in discrimination against people of Asian descent.
Amid the COVID-19 chaos in many hospitals, emergency medicine physicians in seven cities around the country experienced rising levels of anxiety and emotional exhaustion, regardless of the intensity of the local surge, according to a new analysis led by UCSF.
Among a group of 40 health care professionals observed by the study authors, those without masks touched their faces nearly four times as often as those who wore masks, indicating that masks not only are an effective barrier to disease transmission, but also may reduce face-touching, at least among health care professionals.
The researchers determined "medical vulnerability" by referencing indicators identified by the CDC, including heart conditions, diabetes, current asthma, immune conditions (such as lupus, gout, rheumatoid arthritis), liver conditions, obesity and smoking within the previous 30 days. Additionally, the researchers added e-cigarettes to tobacco and cigar use.
Scientists have identified key chemical building blocks for an eventual antiviral drug against SARS-CoV-2, the virus that causes COVID-19.
The declaration of COVID-19 as a global pandemic in March resulted in a rapid decrease in step counts worldwide.
UCSF scientists assembled an international research team that has figured out how SARS-CoV-2, the virus that causes COVID-19, hijacks proteins in host cells that serve as master regulators of key cellular processes.
LGBTQ+ communities have experienced increased anxiety and depression since the onset of the COVID-19 pandemic, especially those who haven’t struggled with these conditions before.
The nationwide clinical trial will assess whether the common antibiotic azithromycin can reduce hospitalization stays and death caused by the SARS-CoV-2 virus.
The finding could offer additional insights into other immune conditions, including a type of childhood leukemia and the severe inflammation response in some children with COVID-19.
Depending on a cancer’s tissue of origin, tumors cause widespread and variable disruption of the immune system throughout the body, not just at the primary tumor site.
Cancer specialists from UCSF will present new research findings at the annual scientific program of the American Society of Clinical Oncology, the world’s largest clinical cancer research meeting.
Smoking significantly worsens COVID-19, according to a new analysis by UCSF of the association between smoking and progression of the infectious disease.
Cancer and autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis, might not seem to have much in common, but some researchers now are pinning hopes on the same immune system cell –
A community-led project to provide comprehensive COVID-19 testing to residents, essential workers, and first responders in the town of Bolinas has determined that all of the 1,845 nasal and oral swab tests conducted in the community between April 20 and April 24 were negative for active infection with the novel coronavirus SARS-CoV-2, which causes COVID-19.
An international team of more than 120 scientists has detailed the impact of 75 over-the-counter prescription and development-stage drug compounds on SARS-CoV-2, the virus that causes COVID-19.
A project launched by UC San Francisco and UC Berkeley scientists evaluated some of the more than 120 available antibody test kits.